VRUS--Would the FDA consider the Bukwang studies as part of the marketing approval package here in the US?
It appears by 2010 it may be on the market with potential labelling upgrades forthcoming. Wonder how long it will take to enroll the pivotals? Any guidance from management, would one speculate a year?